Detalles de la búsqueda
1.
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities.
Nat Immunol
; 24(6): 966-978, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37248417
2.
SARS-CoV-2-specific T cell memory with common TCRαß motifs is established in unvaccinated children who seroconvert after infection.
Immunity
; 55(7): 1299-1315.e4, 2022 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35750048
3.
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.
Immunity
; 54(5): 1066-1082.e5, 2021 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33951417
4.
Circulating effector γδ T cell populations are associated with acute coronavirus disease 19 in unvaccinated individuals.
Immunol Cell Biol
; 101(4): 321-332, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36698330
5.
Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19.
Immunol Cell Biol
; 101(10): 964-974, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725525
6.
Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments.
Gut
; 73(4): 712-714, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36878683
7.
Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents.
Clin Transl Immunology
; 13(3): e1494, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38433763
8.
CD8+ T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age.
Nat Commun
; 15(1): 3387, 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38684663
9.
T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance.
Elife
; 122023 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36655976
10.
Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapy.
EJHaem
; 4(1): 216-220, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36819189
11.
Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab.
Open Forum Infect Dis
; 10(11): ofad550, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38023562
12.
Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations.
JCI Insight
; 8(7)2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37036008
13.
Robust SARS-CoV-2 T cell responses with common TCRαß motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells.
Cell Rep Med
; 4(4): 101017, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37030296
14.
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster.
EBioMedicine
; 98: 104878, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38016322
15.
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine.
ACS Nano
; 16(8): 11769-11780, 2022 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35758934
16.
SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity.
Nat Commun
; 13(1): 2774, 2022 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35589689
Resultados
1 -
16
de 16
1
Próxima >
>>